Inhibition of Herpes Simplex Virus Thymidine Kinases by 2-Phenylamino-6-oxopurines and Related Compounds: Structure−Activity Relationships and Antiherpetic Activity in Vivo
- 11 May 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (11), 3919-3929
- https://doi.org/10.1021/jm049059x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcomeJournal of Neurology, Neurosurgery & Psychiatry, 1997
- Effect of 9-(4-hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, on clinical recurrences of ocular herpetic keratitis in squirrel monkeysAntiviral Research, 1996
- 9-(4-hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, suppresses herpes virus reactivation in miceAntiviral Research, 1996
- Herpes Simplex Virus Infections of the Central Nervous System: Therapeutic and Diagnostic ConsiderationsClinical Infectious Diseases, 1995
- Synthesis, Properties, and Pharmacokinetic Studies of N2-Phenylguanine Derivatives as Inhibitors of Herpes Simplex Virus Thymidine KinasesJournal of Medicinal Chemistry, 1995
- Structure-activity relationships of N2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinasesJournal of Medicinal Chemistry, 1990
- N2-Phenyldeoxyguanosine: a novel selective inhibitor of herpes simplex thymiding kinaseJournal of Medicinal Chemistry, 1988
- Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanineAntiviral Research, 1983
- Treatment of Experimental Herpesvirus Infections with Phosphonoformate and Some Comparisons with PhosphonoacetateAntimicrobial Agents and Chemotherapy, 1978
- Bis (guanidinoethyl) amine DerivativesCHEMICAL & PHARMACEUTICAL BULLETIN, 1969